Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 9, 2011, Pages 1636-1647

  Van Velden, Floris H P ^a   Cheebsumon, Patsuree ^a   Yaqub, Maqsood ^a   Smit, Egbert F ^b   Hoekstra, Otto S ^a   Lammertsma, Adriaan A ^a   Boellaard, Ronald ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cumulative SUV volume histogram (CSH); Intensity volume histograms (IVH); Intratumoural heterogeneity; Positron emission tomography (PET); Standardized uptake value (SUV)

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER SIZE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG TUMOR LEVEL; FEMALE; HISTOGRAM; HUMAN; LIMIT OF QUANTITATION; LUNG NON SMALL CELL CANCER; MALE; OUTCOME ASSESSMENT; WHOLE BODY PET;

AGED; BIOLOGICAL TRANSPORT; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TUMOR BURDEN;

EID: 80955178859     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1845-6     Document Type: Article

References (28)

1. Stroobants SG, D'Hoore I, Dooms C, De Leyn PR, Dupont PJ, De Wever W, et al. Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer. Clin Lung Cancer 2003;4:242-7. (Pubitemid 36758174)
2. Nestle U, Kremp S, Grosu AL. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006;81:209-25. (Pubitemid 44780785)
3. Sørensen M, Horsman MR, Cumming P, Munk OL, Keiding S. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. Int J Radiat Oncol Biol Phys 2005;62:854-61. (Pubitemid 40779779)
4. Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med 2001;42:9-16. (Pubitemid 32104770)
5. Zasadny KR, Tatsumi M, Wahl RL. FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers. Eur J Nucl Med Mol Imaging 2003;30:274-80. (Pubitemid 36686847)
6. Tateishi U, Nishihara H, Tsukamoto E, Morikawa T, Tamaki N, Miyasaka K. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr 2002;26:185-90. (Pubitemid 34233362)
7. Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 2005;46:675-82. (Pubitemid 41716413)
8. Pugachev A, Ruan S, Carlin S, Larson SM, Campa J, Ling CC, et al. Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 2005;62:545-53. (Pubitemid 40704474)
9. Van Baardwijk A, Bosmans G, van Suylen RJ, van Kroonenburgh M, Hochstenbag M, Geskes G, et al. Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in nonsmall cell lung cancer: A feasibility study. Radiother Oncol 2008;87:55-8.
10. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study. J Nucl Med 2004;45:1519-27. (Pubitemid 47618506)
11. van Baardwijk A, Dooms C, van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, et al. The maximum uptake of (18) F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 2007;43:1392-8. (Pubitemid 46874072)
12. O'Sullivan F, Roy S, Eary J. A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data. Biostatistics 2003;4:433-48. (Pubitemid 36810095)
13. O'Sullivan F, Roy S, O'Sullivan J, Vernon C, Eary J. Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET. Biostatistics 2005;6:293-301. (Pubitemid 41240360)
14. El Naqa I, Grigsby P, Apte A, Kidd E, Donnelly E, Khullar D, et al. Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 2009;42:1162-71.
15. Drzymala RE, Mohan R, Brewster L, Chu J, Goitein M, Harms W, et al. Dose-volume histograms. Int J Radiat Oncol Biol Phys 1991;21:71-8.
16. Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005;46:1342-8. (Pubitemid 43733485)
17. van Velden F H P, Cheebsumon P, Yaqub M, Hoekstra OS, Lammertsma AA, Boellaard R. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous tumour FDG uptake in PET studies. Eur J Nucl Med Mol Imaging 2010;37:S262.
18. Boellaard R, Cheebsumon P, van Velden F H P, Yaqub M, Lammertsma AA, Hoekstra OS. A novel cumulative SUV-volume histogram method for parameterizing heterogeneous tumour tracer uptake in oncology FDG PET studies. Eur J Nucl Med Mol Imaging 2010;37:S261.
19. Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med 2007;48:802-10. (Pubitemid 47604982)
20. Hoetjes NJ, van Velden F H P, Hoekstra OS, Hoekstra CJ, Krak NC, Lammertsma AA, et al. Partial volume correction strategies for quantitative FDG PET in oncology. Eur J Nucl Med Mol Imaging 2010;37:1679-87.
21. Tohka J, Reilhac A. A Monte Carlo study of deconvolution algorithms for partial volume correction in quantitative PET. IEEE Nucl Sci Symp Conf Rec 2006;3339-3345.
22. Geets X, Lee JA, Bol A, Lonneux M, Grégoire V. A gradientbased method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 2007;34:1427-38. (Pubitemid 47312577)
23. Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med 2007;48:471-80. (Pubitemid 47604933)
24. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159-71.
25. Jan S, Benoit D, Becheva E, Carlier T, Cassol F, Descourt P, et al. GATE V6: A major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy. Phys Med Biol 2011;56:881-901.
26. Segars WP, Sturgeon G, Mendonca S, Grimes J, Tsui BM. 4D XCAT phantom for multimodality imaging research. Med Phys 2010;37:4902-15.
27. Eary JF, O'Sullivan F, O'Sullivan J, Conrad EU. Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med 2008;49:1973-9.
28. El Naqa I, Bradley J, Guild C, Apte A, Fergus S, Dehdashti F, et al. Pattern recognition analysis of FDG-PET uptake characteristics for assessing response in NSCLC post-radiotherapy treatment. Int J Radiat Oncol Biol Phys 2008;72:S113.